Kim White's battle with adrenocortical carcinoma highlights her resilience and determination to live life fully despite her ...

July brought major breast cancer updates, and CURE is sharing the latest, as recent developments underscore how quickly the landscape continues to evolve.

Imfinzi plus chemo cut progression or death risk in early gastric cancer; the FDA's decision is expected late 2025 following breakthrough designation.

Dr. Jacob Sands discusses progress in lung cancer treatment, as well as what patients should understand about how their care options may evolve over time.

Panelists discuss how patient portal use improves communication by allowing patients to report side effects with photos for ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

Kasey Bowden discussed how confusing the cancer care system can be for patients and families, therefore, having a reliable ...

Cytopenia at myelofibrosis diagnosis raises risk of acute myeloid leukemia and lowers survival, highlighting the need for ...

The CARE Clinic at University of Colorado Hospital was developed to close treatment gaps caused by disparities in cancer care ...

Writing for CURE provided therapeutic relief and purpose after a cancer diagnosis and career change. The COVID-19 pandemic ...

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer ...

Emerging treatments like rusfertide may reduce phlebotomies and improve life for patients with polycythemia vera, according ...